Katherine B Peters

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Histone Deacetylase

Acute Lymphoblastic Leukemia

Top Venues

Neuro-oncology practice

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine B Peters, Jessica Templer, Elizabeth R Gerstner, Thomas Wychowski, Anette M Storstein, Karan S Dixit, Tobias Walbert, Kaitlyn Melnick, Maya Hrachova, Sonia Partap, Nicole J Ullrich, Ashley P Ghiaseddin, Maciej Mrgula
Discontinuation of Antiseizure Medications in Patients With Brain Tumors. Neurology 102 (4) (2024)
Katherine B Peters, Jessica Templer, Elizabeth R Gerstner, Thomas Wychowski, Anette M Storstein, Karan S Dixit, Tobias Walbert, Kaitlyn Melnick, Maya Hrachova, Sonia Partap, Nicole J Ullrich, Ashley P Ghiaseddin, Maciej Mrgula
Discontinuation of Antiseizure Medications in Patients With Brain Tumors. Neurology 102 (4) (2024)
Martin J van den Bent, Pim J French, Daniel J Brat, Joerg-Christian Tonn, Mehdi Touat, Benjamin M Ellingson, Robert J Young, Johan Pallud, Andreas von Deimling, Felix Sahm, Dominique Figarella Branger, Raymond Y Huang, Michael Weller, Ingo K Mellinghoff, Tim F Cloughsey, Jason T Huse, Kenneth D Aldape, Guido Reifenberger, Gilbert Youssef, Philipp Karschnia, Houtan Noushmehr, Katherine B Peters, Francois Ducray, Matthias Preusser, Patrick Yung Wen
The biological significance of tumor grade, age, enhancement and extent of resection in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review. Neuro-oncology (2024)
Bronwen E Foreman, Trey C Mullikin, Scott R Floyd, Chris R Kelsey, Mallika P Patel, Katherine B Peters, John P Kirkpatrick, Zachary J Reitman, Eugene J Vaios
Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma. Neuro-oncology advances 5 (1) (2023)
Trang H Au, Connor Willis, Maija Reblin, Katherine B Peters, Phioanh Leia Nghiemphu, Jennie W Taylor, Howard Colman, Adam L Cohen, David Ryan Ormond, Elizabeth C Neil, Arnab Chakravarti, Nicole Willmarth, Bea Christine Balajonda, Jyothi Menon, Junjie Ma, Hillevi Bauer, Ryan S Nelson, Malinda S Tan, Prianka Singh, Alexander Marshall, Beata Korytowsky, David D Stenehjem, Diana Brixner
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study. Future oncology (London, England) (2023)
Rodeania Peart, Kaitlyn Melnick, Jean Cibula, Tobias Walbert, Elizabeth R Gerstner, Maryam Rahman, Katherine B Peters, Maciej Mrugala, Ashley P Ghiaseddin
Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management. Neuro-oncology advances 5 (Suppl 1) (2023)
Katherine B Peters, Candice Alford, Amy Heltemes, Alicia Savelli, Daniel B Landi, Gloria Broadwater, Annick Desjardins, Margaret O Johnson, Justin T Low, Mustafa Khasraw, David M Ashley, Henry S Friedman, Mallika P Patel
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma. Neuro-oncology practice 11 (2) (2023)
Katherine B Peters, Candice Alford, Amy Heltemes, Alicia Savelli, Daniel B Landi, Gloria Broadwater, Annick Desjardins, Margaret O Johnson, Justin T Low, Mustafa Khasraw, David M Ashley, Henry S Friedman, Mallika P Patel
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma. Neuro-oncology practice 11 (2) (2023)
Holly B Lindsay, Sylvia Cheng, Paul Graham Fisher, Katherine B Peters, Kyle M Walsh, David M Ashley, Annie Huang
Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group. Neuro-oncology advances 5 (1) (2023)
Smita Bhatia, Wendy Landier, Electra D Paskett, Katherine B Peters, Janette K Merrill, Jonathan Phillips, Raymond U Osarogiagbon
Rural-Urban Disparities in Cancer Outcomes: Opportunities for Future Research. Journal of the National Cancer Institute 114 (7) (2022)
Justin Thomas Low, Shih-Hsiu Wang, Katherine B Peters
Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman. CNS oncology 10 (2) (2021)
Jennifer H Kang, Christa B Swisher, Evan D Buckley, James E Herndon, Eric S Lipp, John P Kirkpatrick, Annick Desjardins, Henry S Friedman, Margaret O Johnson, Dina M Randazzo, David M Ashley, Katherine B Peters
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis. CNS oncology 10 (3) (2021)
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, Jennie W Taylor, Alissa A Thomas, Jeffrey S Wefel, Scott L Coven, Alvina A Acquaye, Chas Haynes, Sameer Agnihotri, Michael Lim, Katherine B Peters, Erik P Sulman, Joanne T Salcido, Nicholas A Butowski, Shawn Hervey-Jumper, Alireza Mansouri, Kathy R Oliver, Alyx B Porter, Farshad Nassiri, David Schiff, Erin M Dunbar, Monika E Hegi, Terri S Armstrong, Martin J Van Den Bent, Susan M Chang, Gelareh Zadeh, Milan G Chheda
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neuro-oncology advances 3 (1) (2021)
Breanna Taylor, Mallika P Patel, Katherine B Peters
When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis. CNS oncology 10 (1) (2021)
Jessica M Lewis-Gonzalez, Mallika P Patel, Katherine B Peters
Multi-joint steroid-induced avascular necrosis in a malignant brain tumor patient. CNS oncology 10 (4) (2021)
Syed M Adil, Sarah E Hodges, Ryan M Edwards, Lefko T Charalambous, Zidanyue Yang, Musa Kiyani, Alexis Musick, Beth A Parente, Hui-Jie Lee, Katherine B Peters, Peter E Fecci, Shivanand P Lad
Health care resource utilization and treatment of leptomeningeal carcinomatosis in the United States. Neuro-oncology practice 7 (6) (2020)
Karisa C Schreck, Mallika P Patel, Jan Wemmer, Stuart A Grossman, Katherine B Peters
RAF and MEK inhibitor therapy in adult patients with brain tumors: a case-based overview and practical management of adverse events. Neuro-oncology practice 7 (4) (2020)
Justin T Low, Katherine B Peters
Ibrutinib in primary central nervous system diffuse large B-cell lymphoma. CNS oncology 9 (1) (2020)
Jung-Young Kim, Jennifer G Jackman, Sarah Woodring, Frances McSherry, James E Herndon, Annick Desjardins, Henry S Friedman, Katherine B Peters
Second primary cancers in long-term survivors of glioblastoma. Neuro-oncology practice 6 (5) (2019)
Katherine B Peters, Eric S Lipp, Elizabeth Miller, James E Herndon, Frances McSherry, Annick Desjardins, David A Reardon, Henry S Friedman
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas. Journal of neuro-oncology 137 (2) (2017)